3. Epidemiology and antifungal susceptibility patterns of Candidaemia in a tertiary care hospital in Northern India: Implications for empirical therapy
3. Epidemiology and antifungal susceptibility patterns of Candidaemia in a tertiary care hospital in Northern India: Implications for empirical therapy
4. Biogenic Silver and Gold nanoparticles from M.esculenta: Combating Pan-Drug-resistant from the clinical isolates of patients with urinary tract infections
4. Biogenic Silver and Gold nanoparticles from M.esculenta: Combating Pan-Drug-resistant from the clinical isolates of patients with urinary tract infections
7. Initiating pre-travel vaccination: A critical step for transitioning from the yellow fever vaccination center to the travel clinic: record-based analysis at a Tertiary care Institute, Northern India
7. Initiating pre-travel vaccination: A critical step for transitioning from the yellow fever vaccination center to the travel clinic: record-based analysis at a Tertiary care Institute, Northern India
Author: Ifeyinwa Nwafia, Consultant Clinical Microbiologist; Department of Medical Microbiology, University of Nigeria Teaching Hospital, Enugu, Nigeria
14. A secondary analysis of a phase 3, randomized, double-blind study of v116, a pneumococcal conjugate vaccine, in children and adolescents with increased risk of pneumococcal disease (stride-013)
14. A secondary analysis of a phase 3, randomized, double-blind study of v116, a pneumococcal conjugate vaccine, in children and adolescents with increased risk of pneumococcal disease (stride-013)
16. Observed RSV-associated Cases in the First Week After Clesrovimab Immunization in the Phase 2b/3 CLEVER trial and Pharmacodynamic Modeling Suggest an Early Onset of Protection
16. Observed RSV-associated Cases in the First Week After Clesrovimab Immunization in the Phase 2b/3 CLEVER trial and Pharmacodynamic Modeling Suggest an Early Onset of Protection
18. Clesrovimab Safety, Pharmacokinetics, and RSV-associated Disease Incidence over Two RSV Seasons among Infants at Increased Risk for Severe RSV Disease: Phase 3 SMART Trial
18. Clesrovimab Safety, Pharmacokinetics, and RSV-associated Disease Incidence over Two RSV Seasons among Infants at Increased Risk for Severe RSV Disease: Phase 3 SMART Trial
19. A survey of physician practice, knowledge and attitudes towards penicillin allergy labels and penicillin desensitisation in the intensive care unit
19. A survey of physician practice, knowledge and attitudes towards penicillin allergy labels and penicillin desensitisation in the intensive care unit
24. Gepotidacin and ceftriaxone/azithromycin efficacy by baseline phenotypes and genotypes of Neisseria gonorrhoeae recovered from a clinical trial for uncomplicated urogenital gonorrhoea (EAGLE-1)
24. Gepotidacin and ceftriaxone/azithromycin efficacy by baseline phenotypes and genotypes of Neisseria gonorrhoeae recovered from a clinical trial for uncomplicated urogenital gonorrhoea (EAGLE-1)
25. Antimicrobial activity of ceftolozane/tazobactam and comparators against clinical Gram-negative bacilli collected in the United Kingdom: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2020-2024
25. Antimicrobial activity of ceftolozane/tazobactam and comparators against clinical Gram-negative bacilli collected in the United Kingdom: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2020-2024
26. Antimicrobial activity of imipenem/relebactam and comparators against clinical Gram-negative bacilli collected in the United Kingdom: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2020-2024
26. Antimicrobial activity of imipenem/relebactam and comparators against clinical Gram-negative bacilli collected in the United Kingdom: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2020-2024
27. A Nudge to Safe Dosing and Sound Sleeping: Using Visual Cues to Improve Safety and Sleep Quality of Patients Prescribed Intermittent Intravenous Vancomycin in the Acute Hospital Setting
27. A Nudge to Safe Dosing and Sound Sleeping: Using Visual Cues to Improve Safety and Sleep Quality of Patients Prescribed Intermittent Intravenous Vancomycin in the Acute Hospital Setting
28. A Baseline Evaluation of Intermittent Intravenous Vancomycin Management in the Acute Hospital Setting Following Introduction of an Electronic Prescribing System (HEPMA)
28. A Baseline Evaluation of Intermittent Intravenous Vancomycin Management in the Acute Hospital Setting Following Introduction of an Electronic Prescribing System (HEPMA)
40. A Service Evaluation of clinician interpretation of microbiology reports at two different hospital trusts in the form of an educational survey during World Antimicrobial Resistance Awareness Week
40. A Service Evaluation of clinician interpretation of microbiology reports at two different hospital trusts in the form of an educational survey during World Antimicrobial Resistance Awareness Week
43. Delphi consensus on antimicrobial stewardship in wound care; an evidence-based paradigm shift towards infection prevention, early intervention and treatment using microbial-binding dressings
43. Delphi consensus on antimicrobial stewardship in wound care; an evidence-based paradigm shift towards infection prevention, early intervention and treatment using microbial-binding dressings
46. NHS Pharmacy First Service: Evaluating Antimicrobial Stewardship Through WHO AWaRe Classification and NICE Guideline Concordance in England (2024–2025)
46. NHS Pharmacy First Service: Evaluating Antimicrobial Stewardship Through WHO AWaRe Classification and NICE Guideline Concordance in England (2024–2025)
49. Attempting to reduce attendance in the Emergency Department for patients requiring antibiotics who could have gone to their GP - a Health Equity approach
49. Attempting to reduce attendance in the Emergency Department for patients requiring antibiotics who could have gone to their GP - a Health Equity approach
Author: Kieran Killington, ST5 Infectious Diseases & General Medicine, Guy’s & St Thomas’ Hospital; NIHR Academic Clinical Fellow in Infection, Imperial College London
50. Improving the OPAT referral pathway for syphilis with neurological, ophthalmic or otic involvement: a service evaluation to inform pathway development
50. Improving the OPAT referral pathway for syphilis with neurological, ophthalmic or otic involvement: a service evaluation to inform pathway development
52. From Awareness to Action: Bridging the Knowledge – Practice Gap in Antimicrobial Resistance in Nigeria – A Systematic Review of Community-Based Strategies
52. From Awareness to Action: Bridging the Knowledge – Practice Gap in Antimicrobial Resistance in Nigeria – A Systematic Review of Community-Based Strategies
53. Gepotidacin activity against Escherichia coli and Klebsiella pneumoniae, including molecularly characterised subsets causing urinary tract infections in the UK (2019-2023)
53. Gepotidacin activity against Escherichia coli and Klebsiella pneumoniae, including molecularly characterised subsets causing urinary tract infections in the UK (2019-2023)
55. Investigating Clostridioides difficile infection caused by an emerging virulent strain in individual and pooled human microbiomes using MiGut, an in vitro gut model
55. Investigating Clostridioides difficile infection caused by an emerging virulent strain in individual and pooled human microbiomes using MiGut, an in vitro gut model
59. Optimising Antibiotic Prescribing in Enteric Fever: A Systematic Review of Clinical, Laboratory, and Microbiological Factors Influencing Treatment Outcomes
59. Optimising Antibiotic Prescribing in Enteric Fever: A Systematic Review of Clinical, Laboratory, and Microbiological Factors Influencing Treatment Outcomes
60. Multi-Country Synthesis of Antimicrobial Stewardship Implementation in Low- and Middle-Income Countries: Facilitators, Barriers, and Strategies Across Bangladesh, Nigeria, and India
60. Multi-Country Synthesis of Antimicrobial Stewardship Implementation in Low- and Middle-Income Countries: Facilitators, Barriers, and Strategies Across Bangladesh, Nigeria, and India
84. Can molecular tests replace conventional methods: Rapid Detection of Bacteraemia and Antimicrobial Resistance in Sepsis: Evaluating BioFire BCID2 Panel
84. Can molecular tests replace conventional methods: Rapid Detection of Bacteraemia and Antimicrobial Resistance in Sepsis: Evaluating BioFire BCID2 Panel
Author: Bryan Moreno-Chamba, Predoctoral researcher, Instituto Universitario de Ingeniería de Alimentos-FoodUPV, Universitat Politècnica de València, 46022, Valencia, Spain
95. Assessment of Tedizolid susceptibility against a collection of Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) in comparison with linezolid
95. Assessment of Tedizolid susceptibility against a collection of Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) in comparison with linezolid
Author: Bryan Moreno-Chamba, Predoctoral researcher, Instituto Universitario de Ingeniería de Alimentos-FoodUPV, Universitat Politècnica de València, 46022, Valencia, Spain